Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Midodrine plus Albumin for PICD in ACLF
NCT04474262Unknown
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Jul 2020
- Primary completion
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in acute-on-chronic liver failure (ACLF) comparing Albumin with placebo with Albumin with Midodrine (2 arms). Primary endpoint: Incidence of Paracentesis Induced Circulatory Dysfunction at Day 6. Status: unknown.
02
Drugs
midodrine
03
Conditions
acute-on-chronic liver failure (ACLF)
Beyond the preview
Go deeper on NCT04474262.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04474262.